[Modeling long-term results of basiliximab (SIMULECT) use in patients after kidney transplantation in Great Britain]. / Modelowanie dlugotrwalych skutków stosowania basiliximabu (SIMULECTU) u chorych po przeszczepieniu nerki w Wielkiej Brytanii.
Przegl Lek
; 58(2): 61-6, 2001.
Article
em Pl
| MEDLINE
| ID: mdl-11475844
ABSTRACT
Kidney graft survival prognosis could be performed in relation to the number of acute rejection episodes and their severity. The episodes of rejection could be modelled and based and the results obtained on this way could serve for prediction of a length of graft survival as well as for basiliximab treatment planning.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Proteínas Recombinantes de Fusão
/
Transplante de Rim
/
Rejeição de Enxerto
/
Sobrevivência de Enxerto
/
Imunossupressores
/
Modelos Biológicos
/
Anticorpos Monoclonais
Tipo de estudo:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
Pl
Revista:
Przegl Lek
Ano de publicação:
2001
Tipo de documento:
Article